Evidence map›Paper›PMID 31036669›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2019

Defining the core essential genome of

Bradley E Poulsen, Rui Yang, Anne E Clatworthy, Tiantian White, Sarah J Osmulski, Li Li, Cristina Penaranda, Eric S Lander, Noam Shoresh, Deborah T Hung

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 136 papers.

0numbers the graph read from it
0cells of the map it votes in
136citing papers in PubMed
9.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

136 citing papers in PubMed, 212 citations in OpenAlex.

  1. Review
  2. Distinctive Lacritin Cleavage-Potentiated Bactericidal Alteration of thebioRxiv : the preprint server for biology · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Intracellular barriers and receptor masking limit success of abioRxiv : the preprint server for biology · 2026
    Article
  7. Article
  8. Article
  9. Oligonucleotide genetics forbioRxiv : the preprint server for biology · 2026
    Article
  10. Article
  11. Defining thebioRxiv : the preprint server for biology · 2026
    Article
  12. Review
  13. Functional organization and regulatory logic of theApplied and environmental microbiology · 2026
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

76 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Bradley E PoulsenDepartment of Molecular Biology, Massachusetts General Hospital, Boston, MA 02114.
Rui YangBroad Institute of MIT and Harvard, Cambridge, MA 02142.
Anne E ClatworthyDepartment of Molecular Biology, Massachusetts General Hospital, Boston, MA 02114.
Tiantian WhiteDepartment of Molecular Biology, Massachusetts General Hospital, Boston, MA 02114.
Sarah J OsmulskiDepartment of Molecular Biology, Massachusetts General Hospital, Boston, MA 02114.
Li LiDepartment of Molecular Biology, Massachusetts General Hospital, Boston, MA 02114.
Cristina PenarandaDepartment of Molecular Biology, Massachusetts General Hospital, Boston, MA 02114.
Eric S LanderBroad Institute of MIT and Harvard, Cambridge, MA 02142; lander@broadinstitute.org hung@molbio.mgh.harvard.edu.
Noam ShoreshBroad Institute of MIT and Harvard, Cambridge, MA 02142.
Deborah T HungDepartment of Molecular Biology, Massachusetts General Hospital, Boston, MA 02114; lander@broadinstitute.org hung@molbio.mgh.harvard.edu.
Massachusetts General Hospital · USBroad Institute · USHarvard University · US

Funding

Multiplexed targeting of Pseudomonas aeruginosa essential outer membrane proteinsR33AI098705 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI HUNG, DEBORAH T · 2014 to 2016
$1.3M
NIAID NIH HHS R33 AI098705
6 · The paper itself

Abstract

Genomics offered the promise of transforming antibiotic discovery by revealing many new essential genes as good targets, but the results fell short of the promise. While numerous factors contributed to the disappointing yield, one factor was that essential genes for a bacterial species were often defined based on a single or limited number of strains grown under a single or limited number of in vitro laboratory conditions. In fact, the essentiality of a gene can depend on both the genetic background and growth condition. We thus developed a strategy for more rigorously defining the core essential genome of a bacterial species by studying many pathogen strains and growth conditions. We assessed how many strains must be examined to converge on a set of core essential genes for a species. We used transposon insertion sequencing (Tn-Seq) to define essential genes in nine strains of

Indexed as

Genome, BacterialDNA Transposable ElementsGenes, EssentialModels, StatisticalPseudomonas aeruginosaDNA Transposable Elementsantibiotic discoveryESKAPEgram-negative pathogensTn-Seq

Identifiers

PMID31036669
PMCPMC6525520
OpenAlexW2950731393

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.